Announcements
Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 47 Issue 1 (2020). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.
Original Research
L’azanidazolo nella terapia della trichomoniasi genitale: primi risultati di un'indagine in campo ginecologico
Show Less
1
Universita degli Studi di Torino Scuola Autonoma di Ostetricia di Novara
Clin. Exp. Obstet. Gynecol. 1978, 5(S1), 11–15;
Published: 10 January 1978
Abstract
Azanidazol has been administered to 37 patients with vaginitis produced by Trichomonas vaginalis: 23 have been treated in a combined way (sistemic and topic), 12 in a sistemic way and 2 topically. In 33 (89 %) cases a complete bearing has been achieved, with good tolerance in both patient and partner. On the basis of its efficacy and tolerance, a positive judgement has been expressed regarding the therapeutic validity of drug, supported by other qualities such as antimicrobic spectrus, failed antabuse effect, etc. Among the different ways of administration, the elective is the sistemic followed by the vaginal; while the combined treatment seems to be useless.